Search

everythinglearnresearchcommunity

for

Search:↓

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Children are at risk of health issues from exposure to platinum group elements from car exhausts.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

The document explains how to do skin procedures, care after surgery, and when to use certain treatments.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

Researchers created LabeledIn, a detailed list of drug uses, showing the importance of human input in making such lists.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Human hair provides more UV protection when aligned and at higher angles, but the scalp still gets UV exposure.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.